These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37127508)

  • 1. Comparing the use of high dose to standard dose corticosteroids for the treatment of sudden sensorineural hearing loss in adults - A systematic review.
    Balai E; Gupta KK; Darr A; Jindal M
    Auris Nasus Larynx; 2024 Feb; 51(1):11-24. PubMed ID: 37127508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial.
    Ashtiani MK; Firouzi F; Bastaninejad S; Dabiri S; Nasirmohtaram S; Saeedi N; Ghazavi H; Sahebi L
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):89-97. PubMed ID: 29149379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Use and Timing of Intratympanic Corticosteroid Injections for Sudden Sensorineural Hearing Loss.
    Jin MC; Qian ZJ; Cooperman SP; Alyono JC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):166-173. PubMed ID: 33287664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
    Mirian C; Ovesen T
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):421-428. PubMed ID: 32163109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of super-high-dose steroid therapy in patients with profound sudden sensorineural hearing loss: a comparison with conventional steroid therapy.
    Song MH; Jung SY; Gu JW; Shim DB
    Acta Otolaryngol; 2021 Feb; 141(2):152-157. PubMed ID: 33176548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.
    Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW
    Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis.
    Kovács M; Uzsaly J; Bodzai G; Pap I; Lippai B; Dergez T; Németh A; Gerlinger I; Szanyi I; Bakó P
    Am J Otolaryngol; 2024; 45(1):104099. PubMed ID: 37948820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
    Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Concurrent or Sequential Intravenous and Intratympanic Steroid for Idiopathic Sudden Sensorineural Hearing Loss.
    Chu CH; Chiou SR; Wang MC; Shiao AS; Tu TY; Lin LY; Huang CY; Liao WH
    Audiol Neurootol; 2018; 23(5):277-284. PubMed ID: 30537751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis.
    Kim JY; Han JJ; Sunwoo WS; Koo JW; Oh SH; Park MH; Kim YH
    Auris Nasus Larynx; 2018 Jun; 45(3):447-455. PubMed ID: 28888426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic corticosteroid injection as a first-line treatment of the patients with idiopathic sudden sensorineural hearing loss compared to systemic steroid: A systematic review and meta-analysis.
    Mirsalehi M; Ghajarzadeh M; Farhadi M; Akbarnejad Z; Ahmadi S; Salem MM
    Am J Otolaryngol; 2022; 43(5):103505. PubMed ID: 35714500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial.
    Yang W; Li X; Zhong J; Mei X; Liu H; Yang L; Lu L; Hu H
    Trials; 2020 Feb; 21(1):135. PubMed ID: 32014060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD; Halpin CF; Antonelli PJ; Babu S; Carey JP; Gantz BJ; Goebel JA; Hammerschlag PE; Harris JP; Isaacson B; Lee D; Linstrom CJ; Parnes LS; Shi H; Slattery WH; Telian SA; Vrabec JT; Reda DJ
    JAMA; 2011 May; 305(20):2071-9. PubMed ID: 21610239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of single-dose and multiple divided daily-dose oral steroids for sudden sensorineural hearing loss.
    Yu GH; Choi YJ; Jung HJ; Lim YS; Park SW; Cho CG; Park JH
    Braz J Otorhinolaryngol; 2019; 85(6):733-738. PubMed ID: 30056032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Intratympanic Steroid Dosage on Hearing Recovery in Sudden Sensorineural Hearing Loss.
    Nelson L; Swanson D; Borowiec E; Crossley J; Geng X; Cao X; Kim HJ; Hoa M
    Ann Otol Rhinol Laryngol; 2023 Aug; 132(8):879-887. PubMed ID: 35993281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss.
    Banerjee A; Parnes LS
    Otol Neurotol; 2005 Sep; 26(5):878-81. PubMed ID: 16151332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intratympanic corticosteroid, intravenous batroxobin and combined treatment for sudden sensorineural hearing loss with type-2 diabetes.
    Jia H; Yu Z; Li X; Wang J; Ge X; Chen ZT; Huang X; Wei Y
    Acta Otolaryngol; 2019 Jun; 139(6):522-528. PubMed ID: 31008670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss.
    Tsai HT; Hsueh N; Huang CM; Lin HC
    Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
    Tsounis M; Psillas G; Tsalighopoulos M; Vital V; Maroudias N; Markou K
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
    Zhong SX; Zuo WQ; Zhang BY; Qian Y; Lei Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 53(11):806-810. PubMed ID: 30453397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.